DNA vaccination strategies against infectious diseases

International Journal for Parasitology

Volumn 29, Issue 8, 1999, Pages 1149-1163

  Watts, Allison M ^a   Kennedy, Ronald C ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Animal coccidioses; DNA immunisation; DNA vaccines; Parasitic infections

Indexed keywords

DNA VACCINE;

ACTIVE IMMUNIZATION; ANIMAL PARASITOSIS; ARTICLE; GENE TARGETING; IMMUNOGENICITY; INFECTION PREVENTION; NONHUMAN;

ANIMALS; CLINICAL TRIALS; COCCIDIOSIS; HUMANS; PARASITIC DISEASES; VACCINATION; VACCINES, DNA;

ANIMALIA; PROTOZOA;

EID: 0032870918     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(99)00112-5     Document Type: Article

References (60)

1. Chattergoon M, Boyer J, Weiner DB. Genetic immunzation: a new era in vaccines and immunune therapeutics. FASEB J 1998;11:753-63.
2. Atanasin P. Production de tureurs chez le Hamster par inoculation d'acide doxoxyribonucleique extrait de cultures de tissus infectees par le virus du polyome. Acad Sci 1962;254:1228-4230.
3. Orth C, Atanasin P, Borion M, Rebiere JP, Paoleui C. Infectious and oncogenic effect of DNA extracted from cells infected with polyoma virus. Proc Soc Exp Biol Med 1965;115:1090-5.
4. Israel M, Chan H, Hourihan S, Rowe W, Martin M. Biological activity of polyoma viral DNA in mice and hamsters. J Virol 1979;29:990-6.
5. Will H, Catteneo R, Koch H, Darai C, Schaller H. Cloned HBV DNA causes hepatitis in chimpanzees. Nature 1982;299:740-2.
6. Debensky T, Campbell B, Villarreal L. Direct transfection of viral and plasmic DNA into the liver or spleen of mice. Proc Natl Acad Sci USA 1984;81:7529-33.
7. Wolff JA, Malone RW, Williams P et al. Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465-8.
8. Tang DC, Devit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature (London) 1992;356:152-4.
9. Ulmer JB, Donnelly J, Parker SF et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993;259:1745-9.
10. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines protective immunizations by parenteral mucosal and gene gun inoculations. Proc Natl Acad Sci USA 1993;90:11478-82.
11. Wang B, Ugen K, Srikantan V et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993;90:4156-60.
12. Davis HL, Michel ML, Mancini M, Schleef M, Whalen RG. Direct gene transfer in skeletal muscle; plasmid DNA based immunization against the hepatitis B virus surface antigen. Vaccine 1994;12:1503-9.
13. Conry RM, LoBuglio AF, Kantor J et al. Immune response to a carcinoembryonic antigen polynucleotide vaccine. Cancer Res 1994;54:1164-8.
14. Bright R, Shearer M, Kennedy R. Nucleic acid vaccination against virally induced tumors. Ann NY Acad Sci 1995;772:241-51.
15. Wang B, Merva M, Dang K, Ugen KE, Williams WV, Weiner DB. Immunization by direct DNA inoculation induces rejection of tumor cell challenge. Human Gene Ther 1995;6:407-18.
16. Bright RK, Beames B, Shearer MH, Kennedy RC. Protection against a lethal challenge with SV40-transformed cells by the direct injection of DNA-encoding SV40 large tumor antigen. Cancer Res 1996;56:1126-30.
17. Watanabe A, Raz E, Kohsaka H et al. Induction of antibodies to a κ V region by gene immunization. J Immunol 1993;151:2871-6.
18. Kim JJ, Ayyavoo KJ, Bararazzi ML et al. In vivo engineering of a cellular immune response by co-administration of IL-12 expression vector with a DNA immunogen. J Immunol 1997;158:816-26.
19. Xiang ZQ, Ertl HCJ. Manipulation of the immune response to a plasmid-encoded viral antigen by co-inoculation with plasmids expressing cytokines. Immunity 1995;2:129-37.
20. Raz E, Tighe H, Sato Y et al. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 1996;93:5141-5.
21. Sato Y, Roman M, Tighe H et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996;273:352-4.
22. Benton PA, Kennedy RC. DNA vaccine strategies for the treatment of cancer. Curr Top Microbiol Immunol 1997;226:1-20.
23. Ulmer JB, Deck RR, DeWitt CM, Friedman A, Donnelly JJ, Liu MA. Protective immunity by intramuscular injection of low doses of influenza. Vaccine 1994;12:1541-4.
24. Donnelly JJ, Friedman A, Martinez D et al. Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nat Med 1995;1:583-7.
25. Wang B, Boyer J, Srikanran V et al. Induction of humoral and cellular immune responses to the human immunodeficiency virus type 1 in non-human primates. Virology 1995;211:102-12.
26. Boyer JD, Ugen KE, Wang B et al. Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nat Med 1997;3:526-32.
27. Boyer JD, Ugen KE, Chattergoon M et al. DNA vaccination as anti-human immunodeficiency virus immunotherapy in infected chimpanzees. J Infect Dis 1997;176:1501-9.
28. Yasutomi Y, Robinson H, Lu S et al. Simian immunodeficiency virus-specific cytotoxic T-lymphocyte induction through DNA vaccination of rhesus monkeys. J Virol 1996;70:678-81.
29. Manickan E, Rouse RJD, Yu Z, Wire WS, Rouse BT. Genetic immunization against herpes simplex virus: protection is mediated by CD4+ T lymphocytes. J Immunol 1995;155:259-65.
30. Donnelly JJ, Ulmer JB, Liu MA. Immunization with polynucleotides: a novel approach to vaccination. Immunologist 1994;2(1):20.
31. Kriesel JD, Spruance SL, Daynes RA, Araneo BA. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease. J Infect 1996;173:536-44.
32. Bourne N, Stanberry LR, Bernstein DI, Lew D. DNA immunization against experimental genital herpes simplex virus infection. J Infect Dis 1996;173:800-5.
33. Manickan E, Uy Z, Rouse RJD, Wire WS, Rouse BT. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate early protein, ICP-27. Viral Immunol 1995;8:53-62.
34. Manickan E, Karem KL, Rouse BT. DNA vaccines - a modern gimmick or a boon to vaccinology. Crit Rev Immunol 1997;17:139-54.
35. Huygen K, Conrent J, Denis O et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature 1996;2:983-8.
36. Tascon RE, Colston MJ, Ragno S, Savropoulos E, Gregory D, Lowie DB. Vaccination against tuberculosis by DNA injection. Nat Med 1996;2:888-92.
37. Sedegah M, Hedstrom R, Hobart P, Hoffman SL. Protection against malaria by immunization with circumsporozoite protein plasmid DNA. Proc Natl Acad Sci USA 1994;91:9866-70.
38. Doolan DL, Sedegah M, Hedstrom RC, Hobart P, Charoenvit Y, Hoffman SL. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell: interferon gamma- and nitric oxide-dependent immunity. J Exp Med 1996;183:1739-46.
39. Wang R, Doolan DL, Charoenvit Y et al. Simultaneous induction of multiple antigen-specific cytotoxic T lymphocytes in nonhuman primates by immunization with a mixture of four Plasmodium falciparum DNA plasmids. Infect Immun 1998;9:4193-202.
40. Leitner WW, Seguuin MC, Ballou WR et al. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites. J Immunol 1997;12:6112-9.
41. Schneider J, Gilbert SC, Blanchard TJ et al. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med 1998;4:397-402.
42. Gerloni M, Baliou WR, Billetta R, Zanetti M. Immunity to Plasmodium falciparum malaria sporozoites by somatic transgene immunization. Nat Biotechnol 1997;9:876-81.
43. Waine GJ, Yang W, Scott JC, McManus DP, Kalinna BH. DNA-based vaccination using Schistosoma japonicum (Asian blood-fluke) genes. Vaccine 1997;8:846-8.
44. Dupre L, Poulain-Godefroy O, Ban E et al. Intradermal immunization of rats with plasmid DNA encoding Schistosoma mansoni 28 kDa glutathione S-transferase. Parasite Immunol 1997;19:505-13.
45. Kayes SG, Shaneyfelt RC, Monteiro C, O'Brien JJ. Overproduction of SM28GST in a baculovirus expression vector and its use to evaluate the in vivo immune responses of mice vaccinated against Schistosoma mansoni with naked DNA encoding the SM28GST gene. J Parasitol 1998;84:764-70.
46. Mohamed MM, Shalaby KA, LoVerde PT, Karim AM. Characterization of SM20.8, a member of a family of schistosome tegumental antigens. Mol Biochem Parasitol, in press.
47. LoVerde PT. Do antioxidants play a role in schistosome host-parasite interactions? Parasitol Today 1998;14:284-9.
48. Xu D, Liew F. Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major. Immunology 1995;84:173-6.
49. Sjolander A, Baldwin TM, Curtis JM, Handman E. Induction of a Th1 immune response and simultaneous lack of activation of a Th2 response are required for generation of immunity to leishmaniasis. J Immunol 1998;160:3949-57.
50. Walker PS, Scharton-Kersten T, Rowton ED et al. Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis. Hum Gene Ther 1998;9(13):1899-907.
51. Gurunathan S, Sacks DL, Brown DR et al. Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J Exp Med 1997;187:1137-47.
52. Rothel JS, Boyle DB, Both GW et al. Sequential nucleic acid and recombinant adenovirus vaccination induces host-protective immune responses against Taenia ovis infection in sheep. Parasite Immunol 1997;19:221-7.
53. Rothel JS, Waterkeyn JG, Strugnell RA et al. Nucleic acid vaccination of sheep: use in combination with a conventional adjuvanted vaccine against Taenia ovis. Immunol Cell Biol 1997;75(1):41-6.
54. Jenkins M, Kerr D, Fayer R, Wall R. Serum and colostrum antibody responses induced by jet injection of sheep with DNA encoding Cryptosporidium parvum antigen. Vaccine 1995;13:1658-64.
55. Angus CW, Klivington D, Wyman J, Kovacs JA. Nucleic acid vaccines against Toxoplasma gondii in mice. J Euk Microbiol 1996;43:117S.
56. MacGregor RR, Boyer JD, Ugen KE et al. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J Infect Dis 1998;178:92-100.
57. Wang R, Doolan DL, Le TP et al. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 1998;282:476-80.
58. Minor PD. Regulatory issues in the use of DNA vaccines. Ann NY Acad Sci 1995;772:170-7.
59. Griffiths E. Assuring the safety and efficacy of DNA vaccines. Ann NY Acad Sci 1995;772:164-9.
60. Gilkeson GS, Bloom DD, Pisetsky DS, Clarke SH. Molecular characterization of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. J Immunol 1993;151:1353-64.